The ReadoutAlexion’s future & the 9.9 percent price hike By Damian Garde and Meghana Keshavan Jan. 3, 2018 Reprints Alex Hogan/STAT The Readout for January 03, 2018 About the Authors Reprints Damian Garde National Biotech Reporter Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast. [email protected] @damiangarde Meghana Keshavan Biotech Correspondent Meghana Keshavan covers biotech and contributes to The Readout newsletter. [email protected] @megkesh
The Readout Meghana Keshavan Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
The Readout Damian Garde Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Special Report Lizzy Lawrence STAT Plus: Lured by a bigger payday, a medical device maker sold fake plastic parts. Many were implanted in chronic pain patients
Exclusive Rachel Cohrs STAT Plus: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals
Health Tech Casey Ross, Brittany Trang and Mario Aguilar STAT Plus: What does generative AI mean for health care? We asked the experts
